Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m 6 A methylation

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a commonly used hypoglycemic agent in clinical practice; it inhibits reactive oxygen species-induced pancreatic β-cell apoptosis. N -methyladenosine (m A) is produced by the methylation of RNA N6 residues and has recently been shown t...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology Vol. 924; p. 174960
Main Authors Zhou, Simin, Sun, Yue, Xing, Yujie, Wang, Zhi, Wan, Shujun, Yao, Xinming, Hua, Qiang, Meng, Xiangjian, Cheng, Jinhan, Zhong, Min, Lv, Kun, Kong, Xiang
Format Journal Article
LanguageEnglish
Published Netherlands 05.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a commonly used hypoglycemic agent in clinical practice; it inhibits reactive oxygen species-induced pancreatic β-cell apoptosis. N -methyladenosine (m A) is produced by the methylation of RNA N6 residues and has recently been shown to play a crucial role in the regulation of islet β-cell growth and development. However, the involvement of m A methylation in the β-cell protective effects of exenatide has not been clarified. In this study, the m A-methylated RNA content and methyltransferase-like 3 (METTL3) expression levels in NIT-1 cells and primary mouse islets were found to significantly decrease following treatment with hydrogen peroxide (H O ). Treatment with exenatide induced an increase in m A content and METTL3 expression in the H O -treated NIT-1 cells and islets. Moreover, METTL3 silencing resulted in NIT-1 cell apoptosis under normal culture conditions. METTL3 upregulation significantly ameliorated H O -induced apoptosis in NIT-1 cells and primary islets. Furthermore, the anti-apoptotic effects of exenatide were obviously reversed by METTL3 knockdown. In conclusion, these findings suggest that exenatide elicits its anti-apoptotic effects in pancreatic β-cells by promoting m A methylation through the upregulation METTL3 expression.
ISSN:1879-0712